Why the AFFF Firefighting Foam Cases Still Haven't Settled

If you've been following the firefighting foam litigation, or you're a firefighter or veteran trying to figure out whether the thing is moving, here's the honest snapshot. It's enormous, it's active, and as of this spring nobody has signed a global settlement for the people with cancer claims. The trials that everyone's been waiting on are finally close. That's the state of play, and the rest of this is the why behind it.

This is a neutral rundown of the litigation, not a pitch and not a prediction. The numbers and dates below are as accurate as the public docket allows, and like everything in an active MDL, they move.

What the cases are about

AFFF stands for aqueous film-forming foam, the stuff used for decades to smother fuel fires on military bases, at airports, and by fire departments. It works well. It also contains PFAS, the so-called forever chemicals that don't break down and have been linked in research to several cancers, with the strongest evidence pointing at kidney and testicular cancer.

The lawsuits come in two flavors, and keeping them straight explains a lot. One set is personal injury: firefighters, military personnel, and airport workers who were exposed on the job and later developed cancer. The other is environmental: water utilities, municipalities, and states whose drinking water got contaminated and who want billions to clean it up. Both are aimed at the manufacturers, a roster that includes 3M, DuPont, Chemours, BASF, Tyco, and others. The companies have generally denied that their products caused the claimed harms.

Where it's consolidated

All the federal cases are gathered in a single multidistrict litigation, MDL 2873, in the U.S. District Court for the District of South Carolina, before Judge Richard Gergel. An MDL isn't a class action, which trips a lot of people up. Your case stays your own case. It's just pooled with thousands of others so one judge can handle the shared questions, discovery, expert science, the big common fights, in one place instead of repeating them in courtrooms across the country.

The scale is staggering. As of early 2026 the MDL had something on the order of 15,000 cases pending, and it kept growing month over month as more people connected an old diagnosis to their exposure. That growth is itself a clue about the timeline, because a defendant trying to size up a settlement is aiming at a target that keeps getting bigger.

The part that's already settled, and the part that isn't

Here's a distinction worth pinning down, because headlines blur it constantly. The water-contamination side has seen big money already. 3M agreed to a multibillion-dollar deal with public water systems, and DuPont, Chemours, and Corteva reached a settlement north of a billion dollars on similar claims. Those resolve the cost of cleaning up polluted water supplies.

The personal-injury side, the people with cancer, has not settled. No global deal exists for those plaintiffs as of spring 2026. So someone can read "AFFF settlement, over a billion dollars" and reasonably assume the injured firefighters got paid, when what actually happened is the water utilities did. Two different tracks, two different timelines.

Why these are so hard to settle

Most mass torts are, at bottom, a giant pile of personal-injury claims, and the math to settle them is ugly but knowable. AFFF is harder, and the reason is the mix.

You've got individual cancer victims, you've got municipal water authorities, you've got state governments, and you've got the federal government in the picture through military use and ongoing cleanup obligations. That's personal injury, public health, and environmental remediation tangled into one litigation. Writing checks to injured people is a solved problem. Untangling decades of environmental liability across thousands of contaminated sites, with government defendants and cleanup duties that stretch into the future, is not. The judge has been openly pushing the manufacturers toward settlement, even bringing in a respected mediator, and it still hasn't closed. The complexity is the answer.

What "bellwether trials" means for the timeline

The thing to watch is the bellwether process. The court selects a handful of representative cases, the strongest-organized examples of a given injury, and tries them first. The early trials have been built around the Tier 2 cancers, kidney and testicular, where the science is considered strongest.

These test trials aren't binding on everyone else. A win or loss in a bellwether doesn't decide your neighbor's case. What they do is set a price. When both sides see how real juries react to real evidence and what they award, the guesswork drains out of settlement talks. That's why the looming trial dates matter so much. The conventional read in this kind of litigation is that meaningful trial results, in either direction, are what finally forces a global number. Until then, both sides are negotiating partly blind, which is a big reason the deal hasn't materialized.

A few things that confuse people

Statutes of limitations are real and they vary by state, sometimes tightly. The clock often runs from when you knew or should have known your illness was tied to the exposure, not from the exposure itself, but the windows differ enough that the timing question is genuinely state-specific.

Per-case value is unknown. The figures you see floating around, ranges from the low tens of thousands to several hundred thousand dollars, are lawyer estimates, not established settlement terms. There's no payout grid because there's no settlement. Anyone quoting you a precise number is guessing.

And the foam itself is on the way out regardless of the litigation. The Department of Defense has been phasing AFFF out, and a number of states have set their own deadlines to ban PFAS-containing foam, some landing in 2026. The cleanup and the court fight will outlast the product.

If you're trying to follow this litigation, the federal government's PFAS resources at the EPA are a solid neutral starting point for the science, and the MDL's public docket is where the real procedural movement shows up. The short version for now: big, active, trials close, no global injury settlement yet. We'll update this as the bellwethers actually run.